About the Conference

The Trans-Pacific Health Sciences Dialogue is a meeting for C-level biopharmaceutical industry executives and business development executives who want to accelerate, explore and develop collaborations and partnerships with their counterparts in the most important Trans-Pacific health care markets including Japan, China, South Korea and North America.

This is a must-attend meeting for executives who have, or want to develop, a Trans-Pacific strategy. The event has developed a well-earned reputation as the best place for biopharma companies seeking to forge Trans-Pacific ventures to start exploring their options. Attendees come away with a broad overview and insights they simply will not get in other meetings.

Take a look at some photos from the 2014 Trans-Pacific Health Sciences Dialogue!

Day 1 PhotosDay 2 Photos

In 2015, the Trans-Pacific Health Sciences Dialogue will be held at:

Joseph B. Martin Conference Center
at Harvard Medical School
77 Avenue Louis Pasteur
Boston, MA 02115






Who Should Attend


The Trans-Pacific Health Sciences Dialogue is an event for senior biopharmaceutical executives, KOLs, select industry advisors and members of the financial community with a strategic interest in Trans-Pacific collaboration or investment.

Industry News from FiercePharmaAsia

Read more

Industry News from PharmAsia

  • ViroMed Preps US Trial For First Diabetic Ulcer Gene TherapyAfter receiving US FDA approval to start a Phase III clinical trial with its gene therapy for diabetic peripheral neuropathy earlier this year, South Korea’s ViroMed is set for another Phase III study in the US, this time for a chronic non-healing ischemic diabetic foot ulcer therapy, which is the first gene therapy to be developed for this indication and which the firm is looking to partner.<img src="http://feeds.feedburner.com/~r/_PharmAsiaNews/~4/wld207kdBbY" height="1" width="1" alt="" />
Read more